HNN3.0
Register
Register
Register

UNOMR AG

Start-up

unomr.comZurich, Switzerland
1 profile visit

About

UNOMR, a techBio startup from ETH Zurich, is pioneering single-molecule protein sequencing through their innovative interface nanopore sensor, currently with a focus on site-specific protein glycosylation. Adressing a US$ 60B market, their patented solution has far-reaching applications across healthcare, pharmaceutical development, and food science, offering a powerful new tool for therapeutic discovery and medical food product innovation. Driven by the vision of bringing advanced proteomics directly to the patient, UNOMR aims to catalyze the next breakthrough in precision medicine by making sophisticated protein analysis accessible.

Representatives

ETH Researcher, Co-founder & CEO

UNOMR AG

Marketplace (1)

  • Project cooperation

    Advancing Single-Molecule De-Novo Protein Sequencing

    UNOMR, an ETH Zurich spin-off, is developing novel nanopore sensor for single-molecule protein / PTM sequencing and looking for partners.

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    ETH Researcher, Co-founder & CEO at UNOMR AG

    Zurich, Switzerland